5 assets in Schizophreniform Disorder

Therapeutic assets addressing Schizophreniform Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Dexmedetomidine Schizophreniform Disorder	BioXcel Therapeutics Inc	P4	A (80)
Bazedoxifene Schizophreniform Disorder	The Alfred	P4	BB (65)
Modafinil Schizophreniform Disorder	University of Minnesota	P4	B (62)
Serine D-Form Schizophreniform Disorder	University of Minnesota	P3	B (58)
Minocycline Schizophreniform Disorder	Pakistan Institute of Living and Learning	P1	CC (43)